New Two-Drug sequence aims to extend life in pancreatic cancer
NCT ID NCT05065801
First seen Mar 08, 2026 · Last updated Jun 16, 2026 · Updated 13 times
Summary
This study tests whether giving two different chemotherapy combinations one after the other works better than the standard single combination for people with metastatic pancreatic cancer. About 162 adults aged 18 to 75 with confirmed disease will be randomly assigned to either the sequential treatment or the standard alone. The main goal is to see which approach delays cancer growth longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH de Perpignan
RECRUITINGPerpignan, Pyrénées-Orientales, 66046, France
Contact Email: •••••@•••••
-
CHU Grenoble
NOT_YET_RECRUITINGGrenoble, Auvergne-Rhône-Alpes, 38000, France
Contact Email: •••••@•••••
-
CHU St Eloi
RECRUITINGMontpellier, Herault, 34295, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU St Etienne
ACTIVE_NOT_RECRUITINGSaint-Etienne, Auvergne-Rhône-Alpes, 42000, France
-
Centre Catalan d'Oncologie
NOT_YET_RECRUITINGPerpignan, Pyrénées-Orientales, 66000, France
Contact Email: •••••@•••••
-
Centre Georges-François Leclerc
RECRUITINGDijon, 21079, France
Contact Email: •••••@•••••
-
Institut GODINOT
RECRUITINGReims, Grand Est, 51100, France
Contact Email: •••••@•••••
-
Institut régional du Cancer de Montpellier
RECRUITINGMontpellier, Hérault, 34298, France
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.